CIK 0002006986 · <br>Emerging growth company
Adagio Medical Holdings, Inc.
Sign in to watch- Ticker
- ADGM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (949) 348-1188
- Business address
- 26051 MERIT CIRCLE, SUITE 102, LAGUNA HILLS, CA, 92653
- Former names
- Aja Holdco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Mirsaeedi-Farahani Keyvan Director | Grant or award · Non-qualified stock option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-16 | MISHAN ORLY Director | Grant or award · Non-qualified stock option (right to buy) | +100,000 | 100,000 | ||
| 2026-06-16 | Salmon Sean Director | Grant or award · Non-qualified stock option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-16 | Moran Timothy P. Director | Grant or award · Non-qualified stock option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-16 | Cox James L Director | Grant or award · Non-qualified stock option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-16 | GARDINER SANDRA A. Director | Grant or award · Non-qualified stock option (right to buy) | +30,000 | 30,000 | ||
| 2026-03-06 | Kaster Deborah Chief Financial Officer | Grant or award · Employee Stock Options (Right to Buy) | +490,500 | 490,500 | ||
| 2026-03-06 | Usen Todd Chief Executive Officer | Grant or award · Employee Stock Options (Right to Buy) | +800,000 | 800,000 | ||
| 2025-12-16 | Kaster Deborah Chief Financial Officer | Purchase | +15,000 | $1.20 | $18K | 15,000 |
| 2025-12-12 | Usen Todd Chief Executive Officer | Purchase | +207,315 | $1.09 | $226K | 207,315 |
| 2025-12-11 | Salmon Sean Director | Grant or award · Non-qualified stock option (right to buy) | +90,000 | 90,000 | ||
| 2025-10-20 | PERCEPTIVE ADVISORS LLC Director | Purchase · Tranche A Warrant ("Common Warrant" right to buy) | +1,344,999 | $0.18 | $248K | 1,344,999 |
| 2025-10-20 | PERCEPTIVE ADVISORS LLC Director | Purchase · Tranche B Warrant ("Common Warrant" right to buy) | +1,344,999 | $0.18 | $248K | 1,344,999 |
| 2025-10-20 | PERCEPTIVE ADVISORS LLC Director | Purchase · Tranche C Warrant ("Common Warrant" right to buy) | +1,344,999 | $0.18 | $248K | 1,344,999 |
| 2025-10-20 | PERCEPTIVE ADVISORS LLC Director | Purchase · Pre-Funded Warrant (right to buy) | +2,190,496 | $1.60 | $3.5M | 2,190,496 |
| 2025-03-20 | Cox James L Director | Grant or award · Non-qualified stock option (right to buy) | +90,000 | 90,000 | ||
| 2025-03-20 | Cox James L Director | Grant or award · Non-qualified stock option (right to buy) | +364,000 | 364,000 | ||
| 2025-03-20 | GARDINER SANDRA A. Director | Grant or award · Non-qualified stock option (right to buy) | +90,000 | 90,000 | ||
| 2025-03-20 | Mirsaeedi-Farahani Keyvan Director | Grant or award · Non-qualified stock option (right to buy) | +90,000 | 90,000 | ||
| 2025-03-20 | MISHAN ORLY Director | Grant or award · Non-qualified stock option (right to buy) | +300,000 | 300,000 |
Page 1 of 2 · 30 trades